Compare ASC & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASC | AMPH |
|---|---|---|
| Founded | 2010 | 1996 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 751.7M | 885.4M |
| IPO Year | 2013 | 2005 |
| Metric | ASC | AMPH |
|---|---|---|
| Price | $17.31 | $21.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 8 |
| Target Price | $17.00 | ★ $28.38 |
| AVG Volume (30 Days) | ★ 592.9K | 398.6K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.74% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.81 |
| Revenue | N/A | ★ $719,887,000.00 |
| Revenue This Year | N/A | $6.90 |
| Revenue Next Year | N/A | $4.64 |
| P/E Ratio | ★ $16.60 | $27.17 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.31 | $16.65 |
| 52 Week High | $20.03 | $31.26 |
| Indicator | ASC | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 47.83 | 62.66 |
| Support Level | $15.04 | $18.22 |
| Resistance Level | $17.81 | $22.32 |
| Average True Range (ATR) | 0.62 | 0.61 |
| MACD | -0.09 | 0.08 |
| Stochastic Oscillator | 37.12 | 79.65 |
Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The company markets its services directly to its customers and commercial pool operators and charters its vessels to them through a combination of spot, commercial pooling, and time-charter arrangements. The majority of its revenue is generated from spot voyages, which typically last less than three months.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.